On March 26, US Representative Ro Khanna and PNND Co-President Senator Ed Markey introduced into the US Congress the Investing in Cures Before Missiles (ICBM) Act. The Act would stop the further development of the Pentagon’s new $93-96 billion ground-based strategic deterrent (GBSD) intercontinental ballistic missile (ICBM) and direct those savings towards development of a universal coronavirus vaccine.

An exceedingly challenging agenda of urgent, important, and diverse arms control issues awaits the Biden administration. The New Strategic Arms Reduction Treaty (New START) will surely be a top priority, as well as picking up the pieces left from the Trump administration’s wreckage of the Intermediate-range Nuclear Forces Treaty, the Treaty on Open Skies, and the Joint Comprehensive Plan of Action with Iran. Ambassador James Goodby, member of GSI’s Non-Partisan Security Group, and David A. Koplow , both members of GSI’s Non-Partisan Security Group, reflect in the Bulletin of the Atomic Scientists on possible structures and routes to tackle the vital issues before them. A “do not miss” article.